Overview | Day 1 | Day 2 | Day 3 | Download Brochure | Breakout Discussions

FRIDAY, FEBRUARY 27

8:00am Registration Open and Morning Coffee

VC PANEL: HOW IS PERSONALIZED MEDICINE MOVING FORWARD?

8:30 Moderator: Peter S. Miller, Chief Operating Officer, Genomic Healthcare Strategies

• How have Personalized Medicine business models evolved over the past few years?
• What directions do you see Personalized Medicine taking in the future?
• How will payors be involved? New ways or traditional ways? New payors?
• What factors will influence participation by physicians?

Panelists:

Vance Vanier, M.D., Chief Medical Officer, Navigenics and Partner, Mohr Davidow Ventures

Mickey S. Urdea, Ph.D., Chief Executive Officer, Tethys Bioscience, Inc., and Managing Partner, Halteres Associates, LLC 

David G. Lowe, Ph.D., Managing Director, Skyline Ventures 

Vijay Lathi, Managing Director, New Leaf Venture Partners

MEDICAL EXPERT PANEL: FUTURE OF POINT-OF-CARE 

9:15 Moderator: Keith F. Batchelder, Chief Executive Officer, Genomic Healthcare Strategies
Panelists:
Richard D. Gill, Ph.D., Principal, ActiveCyte Holdings 

Kent B. Lewandrowski, M.D., Associate Professor of Pathology, Harvard Medical School; Associate Chief of Pathology (Operations), Massachusetts General Hospital 

Shuqi Chen, Ph.D., President, Chief Executive Officer, and Chairman of the Board, IQuum 

• How rapidly will the new point of care devices penetrate health care?
• Where will quantitation replace interpretation by MD’s? What impacts will this change have?
• How will quantitative molecular diagnostics, electronic medical records, and patient control relate to one another?
• How will POC quantitative molecular diagnostics allow “quick clinics” to expand the services they offer?
• How will POC quantitative molecular diagnostics influence the growth of chronic disease monitoring and preventive medicine?

10:05 Enabling Personalized Medicine from FFPE Tissue   Austin Tanney, Ph.D., Scientific Liaison Manager, Almac Diagnostics This talk provides an overview of some of the issues surrounding working with FFPE samples and how these can now be addressed. Examples will be given showing the application of RNA profiling in biomarker discovery from FFPE tissue.

Sponsored by

10:20 Coffee Break

BUSINESS EXPERT PANEL: GLOBAL TRENDS 
IN MOLECULAR DIAGNOSTICS

11:00 Moderator: Harry Glorikian, Partner, Scientia Advisors

• Assessing the global drivers of molecular diagnostics
• Gauging market opportunities
• Anticipating potential shifts in the patient care paradigm
• Identifying key issues for adoption

Tiffany Olson, Director, ThermoGenesis Corporation (formerly Chief Executive Officer and President, Roche Diagnostics Corporation)

Panelists:
Howard Grey, Ph.D., Vice President Molecular Diagnostics, PerkinElmer - Genetic Screening (MOVE THIS NAME DOWN PAST THE PHOTO)
Todd Morrill, Head, Acquisitions, Business Development and Strategic Research, Bio-Rad Laboratories

12:00pm Luncheon Presentation (Opportunity Available) or Lunch on your own

POINT-OF-CARE MARKET OUTLOOK AND TECHNICAL DEVELOPMENT 

1:00 Chairperson’s Remarks
Boris Nikolic, M.D., Senior Program Officer, Bill & Melinda Gates Foundation

1:05 Cervical Cancer and Avian Flu
Linda McAllister, M.D., Ph.D., Vice President, Diagnostics, Arbor Vita Corporation

1:35 Low Density Microarrays for Point of Care Diagnostics 
Nick M. Cirino, Ph.D., CBSP, Director, Emerging Technologies Laboratory Director, Applied Genomic Technologies Core Wadsworth Center- NYSDOH
As the leading State public health lab, we are collaborating with industry partners to develop a sensitive and robust POC system which employs low density microarrays. In this way, we have sufficient multiplexing and data richness to make molecular diagnostics affordable and achievable. We have developed cartridges for various applications including Biodefense, TB, STDs, respiratory panels, and encephalitis. The system is cost effective and simple enough for POC applications.

2:05 The PanNAT System for Rapid POC Molecular Detection of Infectious Disease
Karen L. Hedine, President and Chief Executive Officer, Micronics, Inc.
Micronics is advancing a microfluidics-enabled molecular diagnostic platform for detection of infectious disease. The PanNAT system will permit the rapid simultaneous detection of both single and multiplex targets from a small volume of biological sample; no sample pre-processing required. The system includes a portable, battery powered instrument designed for operation in low infrastructure settings. Also included is the disposable cartridge that contains all reagents. Sample to result test time is achieved in 20 minutes.

2:35 Novel Field-Assisted Lab-on-a-Chip System for Rapid Point of Care Diagnosis 
Professor Albert Cheung Hoi Yu, Ph.D., Chairman and Chief Executive Officer, Hai Kang Life Corporation Limited 
We have invented a novel patented field assisted hybridization technology to be used on lab-on-a-chip (LOAC) system. This technology has the capacity to achieve sensitive and accurate detection of nucleic acid in minutes, enabling diagnostic results to be delivered within the hour from sampling stage. Experiments conducted on hepatitis virus and respiratory viruses such as influenza proved its analytical sensitivity and specificity without generating adverse electrolytic effects unlike those observed in other electricity-based chip systems. The LOAC system has tremendous potential application in rapid point of care diagnosis including genotyping that is essential for personalised medicine. We will present the technology behind LOAC and highlight the experimental data generated with this system.

3:05 Close of Conference

Overview | Day 1 | Day 2 | Day 3 | Download Brochure | Breakout Discussions

For more information, please contact Christina Lingham at:
Cambridge Healthtech Institute
250 First Avenue, Suite #300
Needham, MA 02494
Tel: 781-972-5464
Fax: 781-972-5425
email: clingham@healthtech.com  

For sales information, contact
Carol Dinerstein at 781-972-5471 or Dinerstein@healthtech.com 
or
Jon Stroup at 781-972-5483 or jstroup@healthtech.com 
Cambridge Healthtech Institute

250 First Avenue, Suite #300

Needham, MA 02494